XML 48 R36.htm IDEA: XBRL DOCUMENT v3.19.1

Segment Information and Concentrations (Table) (USD $)

3 Months Ended

Mar. 31, 2019

Segment Information And Concentrations Table

Schedule of Operating Segment

Segment net revenues, segment operating expenses and segment contribution information consisted of the following for the three months ended March 31, 2019:

		For the Three Months Ended March 31, 2019
		Pharmaceutical				Pharmaceutical
		Compounding				Drug Development				Total
Net revenues		$	12,290			$	-			$	12,290
Cost of sales			(3,898	)			-				(3,898	)
Gross profit			8,392				-				8,392
Operating expenses:
Selling, general and administrative			5,715				43				5,758
Research and development			125				136				261
Segment contribution			2,552				(179	)			2,373
Corporate, selling, general and administrative											2,719
Research and development											144
Amortization of intangible assets											66
Operating loss										$	(556	)

X

- References

No definition available.

+ Details

Name:	HROW_SegmentInformationAndConcentrationsTableUsdAbstract
Namespace Prefix:	HROW_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration